[Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
D000065:Accommodation, Ocular / Q000187:drug effects; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D014792:Visual Acuity / Q000187:drug effects
D000959:Antihypertensive Agents; D007093:Imidazoles
Catapresan (2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorid)--ein neues augendrucksenkendes Medikament.